| Views | |
|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 86 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 0 | 4 | 11 | 0 | 14 | 7 | 1 |
| Views | |
|---|---|
| 2023_Kreye_etal.pdf | 31 |
